祁慧薇 - 同济大学

个人简介

主持科研项目国家自然科学基金青年项目，81703847，Wnt/β-catenin通路诱导非小细胞肺癌上皮间质转化调控ALK抑制剂耐药及黄连素对其作用研究，2018/01-2020/12，20万元，主持

研究领域

肺癌个体化治疗及耐药机制研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Lihong Fan, Hao Chen, Junliang Teng, Dan Li, Changhui Wang, Qing Xia, Bo Su and Huiwei Qi. Evaluation of Serum-Paired miRNA Ratios for Early Diagnosis of Non-Small Cell Lung Cancer Using Quantum Dot-Based Suspension Array. Journal of Nanomaterials 2018. Lihong Fan, Jie Sha, Junjie Teng, Dan Li, Changhui Wang, Qing Xia, Hao Chen, Bo Su and Huiwei Qi. Evaluation of serum paired miroRNA ratios for differential diagnosis of non-small cell lung cancer and benign pulmonary diseases. Mol Diagn Ther. 2018. Lihong Fan, Huiwei Qi, Junjie Teng, Bo Su, Hao Chen, Changhui Wang and Qing Xia. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for earlydetection of non-small cell lung cancer. Tumour Biol 2016, 37(6): 7777-84. Huiwei Qi, Lingyan Xin, Xin Xu, Xianxiu Ji and Lihong Fan. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis. J Transl Med 2014, 12: 22. Jie Zhang, Huiwei Qi, Yuping Sun, Huikang Xie, Caicun Zhou. Mosquito coil exposure associated with small cell lung cancer: A report of three cases. Oncol lett 2015, 9(4): 1667-1671. Huiwei Qi, Sen Jiang, Dong Yu, Huijuan Ni, Qiong Hu, Jie Zhang. Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer. Med Oncol, 2015,32(12)：256-256. Jie Zhang, Huiwei Qi, Hui Zheng, Mo Chen, Jun Zhu, HuiKang Xie, Jian Ni, Jian-Fang Xu, CaiCun Zhou. Etoposide-Cisplatin Alternating with Vinorelbine-Cisplatin Versus Etoposide-Cisplatin Alone in Patients with Extensive Disease Combined Small Cell Lung Cancer. Asian Pac J Cancer Prev, 2014, 15 (10): 4159-4163. Huiwei Qi, Zan Shen and Lihong Fan. Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line. Exp Ther Med, 2011, 2(6): 1091-1095.